All Insights
Showing 229 - 240 of 400
Life Sciences and Healthcare
Commercialising health data: five takeaways from the ICO's Easylife decision
What actions should businesses consider when looking to reuse customer health data?
Life Sciences and Healthcare
EU General Court says risk of similarity between cosmetics and pharmaceuticals in trade mark cases
A blurred line between goods means skincare products may be considered similar across classes 3 and 5
Regulatory and compliance
New Belgian medical devices and in vitro diagnostics legislation comes into force
The transposition of EU medtech regulations is progressing in Belgium – with repercussions for all medtech businesses active there.
Life Sciences and Healthcare
UK lays out roadmap for regulation of software and AI as medical devices
What 'deliverables' does the MHRA want from its roadmap and what can be expected from its work packages?
Life Sciences and Healthcare
MHRA moves to assuage medical device manufacturers over UK's post-Brexit plans
Businesses will have more time to prepare for the new UKCA marking regime and comment on draft medical device regulations
Intellectual property
Implausible declarations?
What a recent English Patents Court judgment suggests for the future of litigation
Life Sciences and Healthcare
Payback for medical devices: is litigation on the horizon in Italy?
Doubts linger about the system's legitimacy, retroactivity and application, particularly around calculation errors Seven years since the entry into force
Regulatory and compliance
NHS procurement breach not 'sufficiently serious' to award damages
High Court decision raises prospect for claimants of being denied damages even if they succeed in a liability trial
Life Sciences and Healthcare
Zantac clash is reminder for life sciences industry of need for litigation strategies
Robust defences are critical when litigation concerns one product but multiple claimants and jurisdictions
Regulatory and compliance
Details of Bill to relax gene editing rules in UK announced
IP and devolution questions raised as Genetic Technology (Precision Breeding) Bill begins its Parliamentary process
Life Sciences and Healthcare
Cell and gene therapies: solving the skills shortage in the UK
Companies involved in developing cell and gene therapies face challenges in recruiting skilled talent fast enough to keep pace with
Life Sciences and Healthcare
The UK medical devices regime and the impact of the Northern Ireland Protocol
Life Sciences analysis: Peter Rudd-Clarke, partner, and Anna Lundy, associate director, at Osborne Clarke discuss how the medical device industry
